IGF1 and hepatocellular carcinoma: To further corroborate the mechanism of miR-373-3p/TFAP4 axis in HCC, we transfected HCC cells with si-IGF1 or dealt HCC cells with PI3K inhibitor LY294002 following TFAP4 overexpression.